Programmed necrosis in Immune Responses
Programmed necrosis in Immune Responses
批准号:
8049579
负责人:
FRANCIS Kaming CHAN
金额:
$40.71万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2014-03-31
关键词:
AffectApoptosisBiochemicalBiological AssayCASP8 geneCaspaseCaspase InhibitorCell DeathCell membraneCell physiologyCellsCessation of lifeCo-ImmunoprecipitationsComplexCyclic AMP-Dependent Protein KinasesDeubiquitinationEffector CellExhibitsFamily memberGenesHost DefenseHost Defense MechanismImmuneImmune responseImmunityImmunofluorescence ImmunologicIn VitroInfectionInflammationInflammatoryInflammatory ResponseLabelLymphocyteMeasuresMediatingMitochondriaModelingMolecularMorphologyMurid herpesvirus 1MusNecrosisOrthophosphatePKA inhibitorPathway interactionsPermeabilityPhasePhosphorylationPhosphotransferasesPhysiologicalPlayProductionProtein FamilyProtein-Serine-Threonine KinasesProteinsRIPK1 geneRIPK3 geneRNA InterferenceRNA libraryRegulationRoleScreening procedureSignal TransductionTNF geneTestingTissuesTumor Suppressor ProteinsType I Epithelial Receptor CellUbiquitinationVaccinia virusViralVirusVirus DiseasesVirus InhibitorsVirus ReplicationVoltage-Dependent Anion Channelbasecaspase-8cytokinehuman RIPK1 proteinin vivoinhibitor/antagonistloss of functionmembermitochondrial permeability transition poremutantprogramspublic health relevancereconstitution
中文摘要
描述(申请人提供):程序性坏死细胞死亡在形态和机制上不同于细胞凋亡。坏死细胞迅速失去质膜的完整性。内源性“危险信号”的释放会引发炎症,并影响先天和适应性免疫反应的质量和大小。从机制上讲,当半胱天冬酶被抑制时,如在编码半胱天冬酶抑制剂的病毒感染期间,最佳地诱导程序性坏死。程序性坏死的作用被确定为针对程序性坏死的病毒抑制剂,如某些病毒FLIPs (FLICE(caspase-8)样抑制剂蛋白)和小鼠巨细胞病毒(MCMV) M45蛋白。尽管程序性坏死在炎症和抗病毒免疫中的重要性,但调控程序性坏死的分子途径相对不明确。我们试图通过筛选激酶基因的小干扰RNA (siRNA)文库来了解程序性坏死的分子调控。从我们的筛选中,我们确定了受体相互作用蛋白家族的两个成员,RIP1和RIP3,作为tnf诱导的程序性坏死的关键调节因子。在本应用中,我们将研究调节RIP1/ rip3依赖性程序性坏死的分子机制。具体来说,我们将研究蛋白质磷酸化和泛素化在调节RIP1和RIP3活性中的作用。此外,我们将研究RIP1和RIP3激活程序性坏死下游效应期的机制。具体来说,我们将研究促坏死RIP1-RIP3复合体如何调节线粒体通透性过渡孔(mPTP)的功能。最后,我们将以牛痘病毒感染为模型,评估rip3依赖性程序性坏死的生理相关性。具体来说,我们将研究抑制rip3缺陷小鼠的程序性坏死如何影响病毒诱导的坏死、炎症和随后的适应性免疫反应。
英文摘要
DESCRIPTION (provided by applicant): Cell death by programmed necrosis is distinct from apoptosis in morphology and mechanism. Necrotic cells rapidly lose their plasma membrane integrity. The release of endogenous "danger signals" trigger inflammation and can impact the quality and magnitude of innate and adaptive immune responses. Mechanistically, programmed necrosis is optimally induced when caspases are inhibited, such as that during infections with viruses that encode caspase inhibitors. A role for programmed necrosis is bolstered by the identification of viral inhibitors against programmed necrosis, such as certain viral FLIPs (FLICE(caspase-8)-like inhibitor proteins) and the mouse cytomegalovirus (MCMV) M45 protein. Despite the importance of programmed necrosis in inflammation and anti-viral immunity, the molecular pathway that regulates programmed necrosis is relatively undefined. We sought to understand the molecular regulation of programmed necrosis by screening a small interference RNA (siRNA) library of kinase genes. From our screen, we identified two members of the receptor interacting protein family, RIP1 and RIP3, as crucial regulators for TNF-induced programmed necrosis. In this application, we will examine the molecular mechanisms that regulate RIP1/RIP3-dependent programmed necrosis. Specifically, we will examine the role of protein phosphorylation and ubiquitination in regulating RIP1 and RIP3 activity. In addition, we will examine the mechanisms by which RIP1 and RIP3 activates the downstream effector phase of programmed necrosis. Specifically, we will examine how the pro-necrotic RIP1-RIP3 complex modulates the function of the mitochondria permeability transition pore (mPTP). Finally, we will evaluate the physiological relevance of RIP3-dependent programmed necrosis using vaccinia virus infection as a model. Specifically, we will examine how inhibition of programmed necrosis in RIP3-deficient mice affects virus-induced necrosis, inflammation, and subsequent adaptive immune responses.
PUBLIC HEALTH RELEVANCE: Cell death by necrosis causes inflammation and can greatly impact the quality of an immune response. In this proposal, we will study the molecular signals that control cell death by necrosis and evaluate how it impacts the efficiency of immune responses against virus infections. These studies will allow us to better understand the signals that control inflammation and to develop strategies to control it in physiological and pathological conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2020 Cell Death Gordon Research Conference & Gordon Research Seminar
-
批准号:9890344
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2021
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Viral inhibition of cell death in host immune responses
-
批准号:10199958
-
项目类别:
-
资助金额:$59.92万
-
财政年份:2020
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Necroptosis signaling adaptors in inflammatory diseases
-
批准号:9247125
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2016
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Necroptosis signaling adaptors in inflammatory diseases
-
批准号:9106004
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2016
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Regulation of necrotic cell death by protein kinase A and cylindromatosis
-
批准号:7875932
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2010
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Programmed necrosis in Immune Responses
-
批准号:8240975
-
项目类别:
-
资助金额:$40.71万
-
财政年份:2010
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Regulation of necrotic cell death by protein kinase A and cylindromatosis
-
批准号:8034218
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2010
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Programmed necrosis in Immune Responses
-
批准号:8442199
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2010
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Programmed necrosis in Immune Responses
-
批准号:7889520
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2010
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Regulation of TRAIL-induced apoptosis
-
批准号:7669216
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2006
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Regulation of TRAIL-induces apoptosis
-
批准号:7145775
-
项目类别:
-
资助金额:$23.08万
-
财政年份:2006
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Regulation of TRAIL-induced apoptosis
-
批准号:7484235
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2006
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Regulation of TRAIL-induced apoptosis
-
批准号:7282370
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2006
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Role of Programmed Necrosis in Immune Responses
-
批准号:6962426
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2005
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Role of Programmed Necrosis in Immune Responses
-
批准号:7140333
-
项目类别:
-
资助金额:$19.84万
-
财政年份:2005
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Pre-association and Signaling by TNF-like Receptors
-
批准号:6416100
-
项目类别:
-
资助金额:$16.0万
-
财政年份:2002
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
Pre-association and Signaling by TNF-like Receptors
-
批准号:6615079
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2002
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
E2A/HEB MEDIATED TRANSCRIPTIONAL REGULATION IN T CELL DEVELOPMENT
-
批准号:10194508
-
项目类别:
-
资助金额:$45.51万
-
财政年份:1999
-
负责人:FRANCIS Kaming CHAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: